4.6 Article

EPDR1 levels and tumor budding predict and affect the prognosis of bladder carcinoma

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Oncology

Tumour budding in solid cancers

Alessandro Lugli et al.

Summary: Tumour budding serves as an emerging prognostic biomarker in colorectal cancer and other solid cancers, with its predictive accuracy being widely supported by evidence. The standardized scoring system agreed upon at the International Tumour Budding Consensus Conference allows for an independent prediction of pathological features and unfavorable survival outcomes in patients.

NATURE REVIEWS CLINICAL ONCOLOGY (2021)

Article Urology & Nephrology

EPDR1 is related to stages and metastasize in bladder cancer and can be used as a prognostic biomarker

Yue Yang et al.

Summary: EPDR1 expression is associated with tumor stage and metastasis in BLCA, with high expression related to shorter overall survival and involvement in immune cell infiltration. Moreover, EPDR1 is involved in multiple signaling pathways.

BMC UROLOGY (2021)

Article Multidisciplinary Sciences

Tumor budding correlates with tumor invasiveness and predicts worse survival in pT1 non-muscle-invasive bladder cancer

Markus Eckstein et al.

Summary: Tumor budding, identified as single cells or clusters of up to 5 cells at the invasion front, is associated with multifocal tumors, discontinuous invasion pattern, discohesive growth pattern, and extensive lamina propria invasion in pT1 NMIBC patients. Its presence correlates with significantly worse recurrence-free survival, progression-free survival, and cancer-specific survival, making it a potential parameter for patient stratification for BCG therapy or early cystectomy.

SCIENTIFIC REPORTS (2021)

Review Oncology

Advances in bladder cancer biology and therapy

Linda Tran et al.

Summary: Recent developments in bladder cancer research have focused on identifying mutated genes, understanding cellular aspects, and advancing non-invasive diagnostic methods. Immune checkpoint inhibitor therapeutics have shown significant therapeutic impact, providing patients with better monitoring options and hope for prolonged survival.

NATURE REVIEWS CANCER (2021)

Review Urology & Nephrology

The global burden of urinary bladder cancer: an update

Anke Richters et al.

WORLD JOURNAL OF UROLOGY (2020)

Article Oncology

Treatment of muscle-invasive and advanced bladder cancer in 2020

Vaibhav G. Patel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2020)

Article Cell Biology

EPDR1 correlates with immune cell infiltration in hepatocellular carcinoma and can be used as a prognostic biomarker

Ruochan Chen et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)

Review Medicine, General & Internal

Bladder Cancer: A Review

Andrew T. Lenis et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Urology & Nephrology

Tumor Budding: Prognostic Value in Muscle-invasive Bladder Cancer

Laura Lorenzo Soriano et al.

UROLOGY (2019)

Review Oncology

Management of metastatic bladder cancer

Rosa Nadal et al.

CANCER TREATMENT REVIEWS (2019)

Article Pathology

Tumor Budding and Prognosis in Gastric Adenocarcinoma

Niko Kemi et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2019)

Article Oncology

Cancer statistics, 2019

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2019)